Myelofibrosis with Tuberculosis: A Case Report

YK Jin¹, QL Shi¹, CH Peng¹, H Yu¹, XY Zhang¹ and XW Ye^1,

¹Guizhou Provincial People’s hospital, Guiyang, China

Cite this paper

YK Jin, QL Shi, CH Peng, H Yu, XY Zhang and XW Ye. Myelofibrosis with Tuberculosis: A Case Report. American Journal of Medical Case Reports. 2016; 4(7):240-241. doi: 10.12691/AJMCR-4-7-6

Abstract

Myelofibrosis (MF), or fibrosis of the bone marrow, is an uncommon condition. Most cases arise secondary to other disease processes. However, whether tuberculosis can stimulate a secondary fibrotic reaction or develop in patients who have preexisting myeloproliferative disorders is not clear. Here we present a case of a 54-year-old man whose myelofibrosis disappeared completely after administration of antituberculous treatment. The purpose of reporting this case is to reconsider the relationship between tuberculosis and secondary myelofibrosis.

Keywords

myelofibrosis, tuberculosis

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Sohn MH, Kim MW, Lim ST, et al. Unusual bone scintigraphic findings of secondary myelofibrosis associated with disseminated tuberculosis before and after therapy. Clinical nuclear medicine. 2004;29 (11) :706-8.
[2]	Viallard JF, Parrens M, Boiron JM, et al. Reversible myelofibrosis induced by tuberculosis.Clin Infect Dis. 2002;34(12):1641-3.
[3]	Sohn MH, Kim MW, Lim ST, et al. Unusual bone scintigraphic findings of secondary myelofibrosis associated with disseminated tuberculosis before and after therapy.Clin Nucl Med. 2004;29(11):706-8.
[4]	Dyke SC. Some cases of aleukia or aplastic anaemia associated with thrombopaenia. Lancet.1924;1:1048-51.
[5]	Dhamija RK, Chugh S, Yadav RB, et al. Myelofibrosis with myeloid metaplasia due to tuberculosis.J Assoc Physicians India. 1998;46(4):394.
[6]	Morrow LB, Anderson RE. Active tuberculosis in leukaemia,malignant lymphoma and myelofibrosis. Arch Pathol.1965; 79(5):484-93.
[7]	Malur A, Barna BP, Patel J, et al. Exposure to a Mycobacterial Antigen, ESAT-6, Exacerbates Granulomatous and Fibrotic Changes in a Multiwall Carbon Nanotube Model of Chronic Pulmonary Disease. J Nanomed Nanotechnol, 2015. 6(6).
[8]	Verma SC, Agarwal P, and Krishnan MY. Primary mouse lung fibroblasts help macrophages to tackle Mycobacterium tuberculosis more efficiently and differentiate into myofibroblasts up on bacterial stimulation. Tuberculosis (Edinb), 2016. 97: p. 172-80.
[9]	Kim SJ, Lee Y, Kim SH, et al. Extramedullary peritoneal hematopoiesis combined with tuberculosis in a patient with primary myelofibrosis. Med Oncol, 2009. 26(2): p. 238-41.
[10]	Toivari A, Itala-Remes M, Kauppila M,et al. Stem cell transplantation in myelofibrosis. Duodecim. 2011; 127(22): 2375-82.
[11]	Ghanima W, Knutsen H, Delabie J,et al.Primary myelofibrosis--pathogenesis, diagnosis and treatment. Tidsskr Nor Laegeforen.2013;133(18):1946-50.
[12]	Yamamoto M, Ohashi K, Hirashima Y, Kobayashi T, Kakihana K, Akiyama H, Sakamaki H. Poor outcome of myeloablative conditioned allogeneic bone marrow transplantation for myelofibrosis. Intern Med. 2012; 51(10):1183-6.
[13]	Robin M, Giannotti F, Deconinck E,et al. Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis. Biol Blood Marrow Transplant. 2014; 20(11): 1841-6.
[14]	Pilorget H, Bangui A, Adam M: Myelofibrosis Regressing Under Corticotherapy And Intravenous Immunoglobulins In An Infant. Arch Pediatr. 1996; 3(1): 40-3.
[15]	Mesa RA, Elliott MA, Schroeder G, et al. Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia. Mayo Clin Proc. 2004; 79(7): 883-9.